(Times of Israel) Shoshanna Solomon - MeMed Ltd. of Haifa said Wednesday it received a $9.2 million contract from the U.S. Defense Threat Reduction Agency to help complete the development of its bedside device to monitor the body's immune state and help distinguish bacterial from viral infections.
2017-04-21 00:00:00Full ArticleBACK Visit the Daily Alert Archive